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Abstract
  
 Aglaia elliptica Blume belongs to Meliaceae  family which contain an active 
compound of rocaglamid as anticancer. The research was conducted to evaluate the 
biological activities of ethyl acetate fraction of Aglaia elliptica Blume leaves. The dry 
powder of Aglaia elliptica Blume leaves was extracted with methanol using maceration 
method, then was fractionated using n-hexane and ethyl acetate, guided by brine shrimp 
lethality test (BSLT). The most toxic fraction then processed by column chromatography 
and resulted in eight subfractions. Three of them showed the most toxic effect on 
BSLT namely FEA 3.3, FEA 3.4 and FEA 3.5 with LC50 of 40.81, 18.56 and 13.40 ppm 
respectively. The cytotoxic activities of those three active subfractions were assayed 
on HepG2 hepatocarcinoma cells using enzymatic reaction of 3-(4,5-dimethylthiazoyl-
2-yl) 2,5 diphenyltetrazolium bromide (MTT), and the results showed that the IC50 were 
35.10, 14.36 and 14.09 ppm respectively. The most active sub fraction (FEA 3.5) was then 
performed further analyzed using preparative high performance liquid chromatography 
(HPLC). The HPLC results indicated that there were three active compounds, which were 
suspected as derivatives of rocaglamid. The molecular docking simulation indicated that 
rocaglamide formed complex with Toll-like Receptor 4 in HepG2 hepatocarcinoma cells 
and affected the inhibition of  proliferation of its cell. 
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INTRODUCTION
 Hepatocarcinoma is the third leading 
cause of death in the world, especially in Asia. 
Hepatocarcinoma generally occurs in men two times 
more often than in women. Globally, Asian countries 
have 80% of patients with hepatocarcinoma, of 
which approximately 600,000 cases diagnosed 
every year (IARC, 2012). Nowadays the cancer 
management consists of the combination of drug 
uses, surgical for removing of cancer tissue, 
radiation therapy and palliative. But there are still 
limitations on the cancer management, so it needs 
further research for inhibiting the cancer growth, one 
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of which is utilizing medicinal plants. Empirically, 
several medicinal plants have been widely used to 
treat a tumor or cancerous diseases. Antitumor drugs 
of natural contain active compounds that are toxic 
to certain phase of tumor cells cycle but not toxic or 
interfere the normal cells.
 Aglaia sp. belongs to Meliaceae family, has 
potential as an anticancer. Rocaglamid is a bioactive 
compound contained in Aglaia sp. was very effective 
in inhibiting the growth of cancer cells. Previous 
research reported that various rocaglamid derivatives 
have been isolated and identified, and most of them 
showed a very strong cytotoxic potential. Two 
cytotoxic rocaglate derivatives, namely silvestrol 
and episilvestrol were isolated from the fruits and 
twigs of Aglaia silvestris, have an cytotoxic activity 
on KB human oral epidermoid carcinoma cell 
line. (Hwang, et al., 2004). A compound resulted 
from fractionation of Aglaia rubiginosab twigs, 
exhibits potent cytotoxic activity on KB human oral 
epidermoid carcinoma cells (Rivero-Cruz, et al., 
2004)  Many new compounds of silvestrol analogues 
were isolated from stem bark of Aglaia foveolata 
were exhibit cytotoxicity against HT-29 cells (Pan, 
et al., 2010). Several compounds were isolated from 
a combination of fruits, leaves, and twigs and  roots 
of  Aglaia  perviridis,  which had cytotoxic activity 
on  HT-29 human colon cancer cells  (Pan, et al., 
2013).
 The brine shrimp toxicity bioassay is a 
simple method of screening crude plant extracts 
for cytotoxicity (Meyer, et al., 1982). This method 
is an attractive pre-screen for such activities as it 
is relatively simple and inexpensive to test large 
numbers of crude plant extracts in a relatively 
short time, therefore until now still widely used by 
researchers, for example as bioassay to assess the 
bioactivity of the medicinal plants used by eastern 
Nicaraguan healers in traditional medicine (Coe, et 
al., 2010), as a biological model for the preliminary 
selection of pediculicidal components from a 
natural source (Vidotto, et al., 2013), as bioassay 
for screening several methanol extracts of Pacific 
Northwest plants in search of general cytotoxic 
activity (Karchesy, et al., 2016).
 Toll-like receptor 4 (TLR4) is an extracellular 
pathogen recognition receptor (PRR) which 
recognizes a wide range of pathogens and damage 
associated molecular patterns (PAMPs and 
DAMPs). It can activate intracellular signaling and 
transcription factor which participate in transcription 
from either immune related or malignancy genes. 
Thus, TLR4 is an innate immunity receptor which 
plays a pathogenic role during chronic inflammation 
and can induce hepatocellular carcinoma (HCC) in 
human (Sepehri, et al., 2017). TLR4 is known to 
influence growth and migration of hepatocellular 
tumors, and a TLR4 agonist Lipopolysaccharide 
(LPS), was found to significantly upr-egulate TLR4 
expression in HepG2 cells (Hsiao, et al., 2015).
 The research was proposed to identify the 
cytotoxic activities of ethyl acetate fractions of A. 
elliptica Blume leaves extract on hepatocarcinoma 
cancer cell lines HepG2, and molecular docking 
simulation to analyzed the interaction between 
rocaglamide with TLR4. 
 
MATERIALS AND METHODS 
Extract Preparation
 The dried powder simplicia of A. elliptica 
Blume was macerated using methanol distillate 
with stirring, the process was repeated 3 times. 
then allowed to stand for 24 hours and then was 
filtered. The filtrate was then concentrated by 
vacuum rotary evaporator to obtain a methanol 
crude extract. Subsequently, the methanol crude 
extract was fractionated using n-hexane and ethyl 
acetate solvents, until obtained three extract phase, 
namely  n-hexane phase, ethyl acetate phase and 
methanol-water phase.   Each partition filtrates then 
were evaporated and then the results are analyzed 
qualitatively by thin layer chromatography (TLC) 
and high-performance liquid chromatography 
(HPLC). To confirm the biological activity of 
extract fractions were tested using brine shrimp 
lethality test (BSLT).
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Isolation of Active Compound
 Active compounds isolation performed by 
column chromatography and semi-preparative 
HPLC, guided by TLC and analytical HPLC. From 
the extraction and the partitioning process resulted 
in three extract phases, namely n-hexane phase, 
ethyl acetate phase, and methanol-water phase. 
Subsequently, ethyl acetate phase was separated 
using Vacuum Liquid Chromatography (VLC) 
with the 15 cm column length and 4 cm column 
diameter. Silica gel 60 Merck was used as stationary 
phase, and the mobile phase was combination 
between dichloromethane and methanol (9.5:0.5) 
with the following gradient ratio:dichloromethane 
100%, 20:80, 60:40, 80:20, 5:100% methanol. The 
resulting fractions then were analyzed by TLC using 
the same mobile phase mixture of dichloromethane-
methanol and for the stationary phase was silica 
gel GF 254. and also analyzing qualitatively using 
HPLC. Purification extract then continued using 
semi preparative HPLC using the reverse phase 
C18 as stationary phase, and the combination of 
methanol-water as mobile phase. The column 
length was 15 cm and the diameter were 5 mm, the 
injection volume was 200 µL and the flow rate was 
4.70 mL/min.
Brine Shrimp Lethality Test (BSLT)
 Preliminary screening of biological activity 
of crude extract and fractions resulted from 
partitioning using semi preparative HPLC and VLC 
of A. elliptica extract were subjected to the BSLT. 
The stock solution sample was prepared in the 
1000 µg/mL by diluted in the dimethyl sulfoxide 
(DMSO). Then each sample of crude extract and 
fractions were diluted at concentration of 100 µg/
mL in marine solution, in triplicate. Briefly, these 
samples were solubilized in 5 mL of marine solution 
with 1% DMSO (v/v), and 20 nauplii of brine 
shrimp were added in each flask and maintained 
in direct contact with the sample solutions for 24 
hours. A magnifying glass, a light focus and a dark 
background were used to conduct the observations. 
The same procedure was followed with samples 
from semipreparative HPLC which was prepared 
in the 50 µg/mL, and the samples from VLC 
fractionation were prepared at concentrations of 5, 
10, 20, 40 and 60 µg/mL in triplicate (Vidotto, et 
al., 2013). 
Cytotoxicity Assay Using MTT Method
 The HepG2 human hepatocarninoma 
cells was maintained as monolayer cultures in 
Roswell Park Memorial Institute (RPMI) 1640 
medium, supplemented with  antibiotics 100 IU/
mL penicillin and 100 µg/mL streptomycin and 
10% fetal bovine serum in a humidified incubator 
containing 5% CO2 at 37°C. Subcultures were 
obtained by trypsin treatment of confluent cultures. 
The cells were plated in 100 µL of medium into 96 
micro well plates at a density of 5x103 cells/well, 
and incubated at 37oC and 5% CO2 incubator. One 
day later the cell culture medium in each wells was 
discarded and added with 100 µL of fresh medium 
containing the indicated concentrations (0, 5, 10, 
20, 40, 60 and 80 µg/mL) of extract in triplicate. 
After 24 hours of treatment, the cell culture medium 
was removed and replaced with fresh medium 
containing of 0.5 mg/ml of MTT and maintained at 
37ºC in 5% CO2 incubator for 4 hours to allow MTT 
to be converted to formazan crystals by reacting it 
with metabolically active cells. The reaction was 
stopped by added sodium dodecyl sulfate (SDS) 
10%, and the absorbance was measured at 570 nm 
using an ELISA plate reader (Wang, et al., 2000). 
RESULTS
Extract Preparation
 The extraction of 1.8 kg A. elliptica Blume 
dried leaf powder using methanol solvent resulted 
in 15.52% yield of crude methanol extract as much 
as 279.36 g. The partitioning process of the crude 
methanol extract obtained the following extract 
phase, namely  n-hexane phase, ethyl acetate phase 
and methanol-water phase. The biological activities 
of  those  crude  extract  and  extract  phases  on 
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BSLT at 100 µg/mL resulted the percent mortality 
about 60-86.67%  (Table 1). Then all of the extract 
and phase extracts were analyzed qualitatively by 
TLC  which  were  detected  on  366  nm  of  UV 
(Figure 1A). 
Extract / phase Yield (g) Mortality (%)
Crude methanol extract 279.36 80
n-hexane phase 24.70 63.33
Ethyl acetate phase 23.38 86.67
Methanol-water phase 54.04 60
Table 1. Yield of A. elliptica leaves crude extract and 
phase extracts, and their toxicities on BSLT.
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Figure 1. Thin Layer Chromatography (TLC) profile of the A. elliptica Blume crude extract and its fractions. A: 
TLC profile of crude extract and three extract phases resulted from partition process: 1: Methanol crude ex-
tract; 2: n-hexane, 3: ethyl acetate and 4: methanol-water phases. B: TLC profile of the ethyl acetate phase 
and its fractions resulted from the vacuum liquid chromatography (VLC) fractionations: 1: F.EA (Ethyl acetate 
Phase); 2: F.EA.1; 3: F.EA.2; 4: F.EA.3; 5: F.EA.4; 6: F.EA.5 and 7: F.EA.6 fractions. C: TLC profile of the ethyl ace-
tate subfractions resulted from the column chromatography fractionations of ethyl acetate of F.EA.3 fraction. 1: 
F.EA.3.1; 2: F.EA.3.2; 3: F.EA.3.3; 4: F.EA.3.4; 5: F.EA.3.5; 6: F.EA.3.6; 7: F.EA.3.7 and 8: F.EA.3.8 subfractions.  
Isolation of Active Compound 
 Six fractions were resulted from 20 g ethyl 
acetate phase extract using VLC. Each fraction 
was  then analyzed using TLC (Figure 1B) and also 
determined for their biological activities by BSLT 
at 50 µg/mL. The toxicity tests with BSLT indicated 
that  the  fraction  F.EA.2  was most toxic among 
other fractions with a mortality score of 76.67% 
followed by the F.EA.3 with a mortality score 70% 
(Table 2). Whereas the yield of F.EA.3 (4.588 g) 
was much higher than F.EA.2 fraction (2.075 g). 
Therefore F.EA.3 fraction would be proceeded 
to the next purification process using column 
chromatography.
Extract 
Fractions
Gradients Eluent 
Dichloromethane : 
Methanol
Fraction 
Yield (g)
Mortality 
(%)
 F.EA.1 100 : 0 0.6369 50
 F.EA.2 80 : 20 2.0754 76.67
 F.EA.3 60 : 40 4.5882 70
 F.EA.4 40 : 60 2.8228 58.3
 F.EA.5 20 : 80 1.239 53.33
 F.EA.6 0 : 100 0.2093 51.67
Table 2. The yield of extract fractions of A. elliptica 
Blume resulted from VLC fractionations and 
their toxicities on BSLT.
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Table 3. The subfractions of A. elliptica Blume resulted 
from column chromatography fractionations and 
their biological activities on BSLT.
 Fractionation of the F.EA.3 using column 
chromatography resulted in 8 subfractions. Then 
the biological activities of each subfraction were 
tested on BSLT 50 µg/mL and to identify the 
active compound contained in the subfraction were 
analyzed using TLC (Figure 1C). The yield of each 
subfraction, and biological activities on BSLT could 
be seen in Table 3.
Subfractions Yield (mg) Mortality (%)
 F.EA.3.1 134.2 41.67
 F.EA.3.2 479 48.33
 F.EA.3.3 366.8 50
 F.EA.3.4 168 58.33
 F.EA.3.5 122.4 68.33
 F.EA.3.6 23.1 48.33
 F.EA.3.7 14.9 48.33
 F.EA.3.8 97.4 31.67
Cytotoxicity Assay
 The cytotoxicity assay was conducted to 
the three subfractions which exhibited most toxic 
effect on the BSLT, namely F.EA.3.3; F.EA.3.4 and 
F.EA.3.5 subfractions. The cytotoxic activities of 
those subfractions were analyzed of against HepG2 
human hepatocarcinoma cells using MTT method. 
The effect of each subfractions on hepatocarcinoma 
cell viability could be seen in Table 4 and Figure 2.
Subractions LC50 (µg/mL) IC50 (µg/mL)
 F.EA.3.3 40.81 35.1
 F.EA.3.4 18.56 14.96
 F.EA.3.5 13.4 14.09
Table 4. The  subfractions  of  A.  elliptica  Blume 
resulted from column chromatography fraction-
ations and their toxicity on BSLT (LC50) and cyto-
toxic activities on HepG2 hepatocarcinoma cells 
(IC50).
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Figure  2.  The cell  viability  of 
HepG2 hepatocarcinoma  cells 
on various concentrations of A. 
elliptica Blume ethyl acetate 
fraction treatments.
Semi-preparative HPLC Separation
 The semi-preparative HPLC separation of 
FEA 3.5 fraction was conducted and 10 isolates 
were obtained, which were accommodated at 
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minute of 11, 12, 13, 14, 17, 19, 21, 23 and 24. The 
isolates were then analyzed by analytical HPLC. 
Three isolates namely 4, 5 and 6 were identified 
on analytical HPLC and predicted as rocaglamid 
derivative, the chromatogram of those isolates 
could be seen on Figure 3 -5.
A
B
Figure 3. The chromatogram of analytical HPLC (A) 
and UV spectrum (B) of isolate 4 of FEA 3.5 sub-
fraction at the 12th and 14th minutes.
A
B
Figure 4. The chromatogram of analytical HPLC (A) 
and UV spectrum (B) of isolate 5 of FEA 3.5.5 
subfraction at the 14th and 16th minutes
Interaction between Rocaglamide with TLR4
 Molecular docking simulation of rocaglamide 
into TLR4 was performed to predict the cytotoxic 
mechanism. The 3D structure of TLR4 was 
downloaded from Protein Data Bank (PDB ID: 
4G8A) which formed complex with LPS (Figure 
6). Rocaglamide as ligand was docked at the 
replacement of LPS position. Rocaglamide formed 
complex with TRL4 with affinity energy binding 
prediction about -63 kcal/mol. It interacted with 
amino acid residue Ser 120 chain C and Lys133 
Chain D of TLR4 (Figure 7). These interactions will 
affect to inhibiting of the TRL4 activity in HepG2 
cells proliferation. 
DISCUSSION
 
The biological activity of ethyl acetate fraction 
of A. elliptica leaf extract was evaluation. Aglaia 
leaf dry powder was extracted with methanol by 
maceration, then partitioned using hexane and ethyl 
acetate solvents with guided by BSLT.   The resultant 
partition was obtained by the most toxic phase of ethyl 
149
Churiyah, et al, 2018
Indones. J. Cancer Chemoprevent., 9(3), 143-151
B
A
Figure 5. The chromatogram of analytical HPLC (A) 
and UV spectrum (B) of isolate 6 of FEA 3.5.6 
subfraction at the 18th minutes.
Figure 6. Docking rocaglamide 
into TLR4 as a receptor  tar-
get for cytotoxic of HepG2 
hepatocarcinoma cells.
acetate in the BSLT test. Further, the ethyl acetate 
phase was fractionated by column chromatography 
and 8 fractions were obtained, of which 3 fractions 
showed the highest activity in the BSLT. The result 
of sub-fractions of A. elliptica Blume resulted from 
column chromatography fractionations on BSLT 
indicated the strong activities whereas the LC50 were 
13.40-40.81 µg/mL because in the BSLT the sample 
was included strong toxicity when the LC50<100 
µg/mL and highest activity if the LC50<10 µg/mL 
(Karchesy, et al., 2016).
 Furthermore, three subfractions from column 
chromatography that were active on BSLT were 
continued with the cytotoxicity test on HepG2 
hepatocarcinoma cells by MTT method. In the 
cytotoxic test it was known that the three fractions of 
FEA 3.3, FEA 3.4 and FEA 3.5 showed IC50 values 
of 35.10, 14.36 and 14.09 μg/mL, respectively. The 
effect of each subfractions on hepatocarcinoma cell 
viability was dose dependent manner, increasing 
the sample concentration would decreased the cell 
viability. Among the three fractions, the F.EA.3.5 
showed most cytotoxic activity than others, 
indicated with smallest IC50 value that was about 
14.9 μg/mL. The result of cytotoxicity test was 
positive correlation with BSLT, whereas the most 
toxic on BSLT also  most toxic on HepG2 cell, and 
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Figure 7. Interaction of rocaglamide with amino acid residue of TLR4.
conversely the less toxic on BSLT was also exhibited 
less cytotoxic on HepG2 cells. Previous research 
using various rocaglate derivatives from Aglaia 
perviridis leaves extract against HepG2 cells showed 
that the cytotoxic activities of those compounds with 
IC50 values varied between 0.014 - more than 50 μM 
(An, et al., 2016). 
 After it was suspected that rocaglamid is the 
active fraction of A. elliptica extract in inhibiting 
HepG2 cell proliferation, then a docking simulation 
was performed to predict the interaction between 
rocaglamid  and  TLR4,  whereas  rocaglamide 
as ligand was docked at the replacement of 
Lipopolysaccharide position. Downregulation of 
TLR4 induces suppressive effects on hepatitis B 
virus-related  hepatocellular  carcinoma,  proven 
by  the mRNA and protein levels of TLR4 were 
significantly increased in HepG2.2.15 cells. 
Downregulation of TLR4 significantly decreased the 
proliferation and induced apoptosis in those cells. In 
addition, TLR4 showed a physical interaction with 
HBx, which plays a tumor-promoting role in HBV-
related HCC cells, therefore TLR4 may be a potential 
therapeutic target for HBV-related HCC (Wang, et 
al., 2015).
CONCLUSION
 An active subfraction was obtained from 
chromatography separations of A. elliptica Blume 
leaves ethyl acetate fraction which exhibited 
strong activities against A. salina in the BSLT and 
also significantly reduced the viability of HepG2 
hepatocarcinoma cells. This activity due the 
rocaglamid contained in the its active subfraction, 
where the molecular docking simulation indicated 
that rocaglamide formed complex with TLR4 in 
HepG2 hepatocarcinoma cells and affected the 
inhibition of  proliferation of its cell. 
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